news & events

Check out what we’ve been up to and where can we connect!


Remdisivir superior to standard care for hospitalized adults with COVID-19: Final ACTT-1 results published in NEJM

October 8, 2020
Final results of the Adaptive COVID-19 Treatment Trial (ACTT)-1 investigating remdesivir for the treatment of COVID-19 in hospitalized adults with evidence of lower respiratory tract involvement have been published in the New England Journal of Medicine (NEJM). Of the FHI Clinical study team members, Danielle Fisher, Clinical Research Project Manager, and Wendi McDonald, Associate Project Manager, are listed on the manuscript for their contributions to the study.

Read More »


MTEC’S 5th Annual Membership Meeting

An FHI Clinical representative will be present at the Medical Technology Enterprise Consortium’s (MTEC) 5th Annual Membership Meeting in Houston, TX, March 4-5, 2020. Set up a meeting to discuss FHI Clinical’s global operational experience.

Read More »